| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |